Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Denali Capital Acquisition Corp.

Get SEC filing alerts via email and in your feed for Denali Capital Acquisition Corp.

DECA DECAU DECAW DNQAF DNQWF DNQUF

Denali Capital Acquisition Corp.

About Denali Capital Acquisition Corp.

A blank check company incorporated in the Cayman Islands, Denali Capital Acquisition Corp. aims to identify and complete mergers or acquisitions with businesses in technology, hospitality, or consumer services. It provides a streamlined route for target companies to go public via business combination, leveraging its industry expertise, broad network, and strategic criteria to generate value and access capital markets. The company operates as a shell entity until executing its initial business combination.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Denali Capital Acquisition Corp.

1
1
Denali Capital Acquisition Corp. Semnur Pharmaceuticals Reports $4.6 Million Net Loss and Increased Operating Expenses in Latest 10-Q

Via official filing (AI summary) | 22 days ago | 0 comments

2
1
Denali Capital Acquisition Corp. Semnur Pharmaceuticals Reports $160.4 Million Net Loss for 2025, Advances SP-102 Trials

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Denali Capital Acquisition Corp. Semnur Pharmaceuticals Reports $152.6 Million Net Loss in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Denali Capital Acquisition Corp. Denali Capital Reports $385K Net Loss in Q2 2025 Amid Asset Decline

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Denali Capital Acquisition Corp. Denali Capital Acquisition Corp. Reports $194,603 Net Loss and Pursues Merger with Semnur Pharmaceuticals

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Denali Capital Acquisition Corp. Denali Capital Acquisition Corp. Reports $167K Net Loss and Pursues Merger with Semnur Pharmaceuticals

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Denali Capital Acquisition Corp. Denali Capital Acquisition Corp. Reports Significant Financial Decline, Net Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments